SEC Filing Summary

Wang Xiaodong, Chair of the Scientific Advisory Board and a director of BeOne Medicines Ltd., reported several transactions on September 8, 2026. These include the sale of American Depositary Shares (ADS) totaling 63,857 shares at prices ranging from $344.71 to $351.25. The total value of these sales is approximately $22.3 million. Additionally, Mr. Wang acquired 31,027 ADS at a price of $36.90 per share, totaling $1,144,770.30. He also exercised an option to acquire 403,351 ordinary shares underlying the option, with a reported exercise price of $2.84 per share. Following these transactions, Mr. Wang directly owns 4,588,113 ordinary shares and indirectly owns 1,025,063, 3,953,100, and 50 ordinary shares through various holdings. The filing also includes a limited power of attorney granted by Xiaodong Wang to specific individuals to execute SEC forms on his behalf.